These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3291971)

  • 1. Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator.
    Webb J; Vitolo ML
    Birth Defects Orig Artic Ser; 1988; 23(5B):63-70. PubMed ID: 3291971
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical studies of pyridoxal isonicotinoyl hydrazone relevant to its clinical evaluation.
    Vitolo ML; Clare BW; Hefter GT; Webb J
    Birth Defects Orig Artic Ser; 1988; 23(5B):71-9. PubMed ID: 3390576
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyridoxal isonicotinoyl hydrazone and its analogues.
    Buss JL; Hermes-Lima M; Ponka P
    Adv Exp Med Biol; 2002; 509():205-29. PubMed ID: 12572996
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.
    Hershko C; Avramovici-Grisaru S; Link G; Gelfand L; Sarel S
    J Lab Clin Med; 1981 Jul; 98(1):99-108. PubMed ID: 7252329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
    Richardson D; Baker E; Ponka P; Wilairat P; Vitolo ML; Webb J
    Birth Defects Orig Artic Ser; 1988; 23(5B):81-8. PubMed ID: 3390577
    [No Abstract]   [Full Text] [Related]  

  • 6. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.
    Richardson DR
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2061-3. PubMed ID: 9303419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
    Buss JL; Neuzil J; Ponka P
    Arch Biochem Biophys; 2004 Jan; 421(1):1-9. PubMed ID: 14678779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro.
    Ponka P; Richardson DR; Edward JT; Chubb FL
    Can J Physiol Pharmacol; 1994 Jun; 72(6):659-66. PubMed ID: 7954097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC study on stability of pyridoxal isonicotinoyl hydrazone.
    Kovaríková P; Mokrý M; Klimes J; Vávrová K
    J Pharm Biomed Anal; 2006 Jan; 40(1):105-12. PubMed ID: 16061341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
    Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits.
    Adamcová M; Machácková J; Gersl V; Pelouch V; Simůnek T; Klimtová I; Hrdina R; Ponka P
    Physiol Res; 2002; 51(5):443-8. PubMed ID: 12470196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
    Buss JL; Arduini E; Shephard KC; Ponka P
    Biochem Pharmacol; 2003 Feb; 65(3):349-60. PubMed ID: 12527328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties.
    Buss JL; Neuzil J; Gellert N; Weber C; Ponka P
    Biochem Pharmacol; 2003 Jan; 65(2):161-72. PubMed ID: 12504792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
    Buss JL; Arduini E; Ponka P
    Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone.
    Bláha K; Cikrt M; Nerudová J; Ponka HF
    Blood; 1998 Jun; 91(11):4368-72. PubMed ID: 9596686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents.
    Richardson DR; Tran EH; Ponka P
    Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.
    Richardson DR; Milnes K
    Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
    Hermes-Lima M; Gonçalves MS; Andrade RG
    Mol Cell Biochem; 2001 Dec; 228(1-2):73-82. PubMed ID: 11855743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against *OH-mediated strand breaks.
    Hermes-Lima M; Nagy E; Ponka P; Schulman HM
    Free Radic Biol Med; 1998 Nov; 25(8):875-80. PubMed ID: 9840731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.